It should be noted that overall, the effect of DPP-4 inhibitors appears to be modest, although large RCTs with histological endpoints are lacking to conclusively establish their role in patients with T2DM and NASH. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.